Pigs aerogenously immunized with genetically inactivated (ghosts) or irradiated Actinobacillus pleuropneumoniae are protected against a homologous aerosol challenge despite differing in pulmonary cellular and antibody responses

Journal of Biotechnology

Volumn 73, Issue 2-3, 1999, Pages 251-260

  Katinger, Astrid ^a,b   Lubitz, Werner ^a   Szostak, Michael P ^a   Stadler, Maria ^a,b   Klein, Reinhard ^a   Indra, Alexander ^a   Huter, Veronika ^a   Hensel, Andreas ^a,c  

^a Institute of Microbiology and Genetics Vienna   (Austria)

^b UNIVERSITY OF VETERINARY MEDICINE   (Austria)

^c UNIVERSITY OF LEIPZIG   (Germany)

Author keywords

Actinobacillus pleuropneumoniae; Aerosol immunization; Bronchoalveolar lavage (BAL); ELISA; Ghosts; Lymphocyte subsets; Pig

Indexed keywords

AEROSOLS; ANTIBODIES; ASSAYS; BACTERIA; CELLS; GENETIC ENGINEERING; VACCINES;

ACTINOBACILLUS PLEUROPNEUMONIAE; BRONCHOALVEOLAR LAVAGE; LYMPHOCYTES;

IMMUNIZATION;

CD4 ANTIGEN; CD8 ANTIGEN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; LIVE VACCINE;

ACTINOBACILLUS PLEUROPNEUMONIAE; AEROSOL; ANIMAL CELL; ANIMAL EXPERIMENT; ANTIBODY RESPONSE; CELLULAR IMMUNITY; CONFERENCE PAPER; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; GRANULOCYTE; IMMUNIZATION; IMMUNOCYTOCHEMISTRY; INHALATIONAL DRUG ADMINISTRATION; IRRADIATION; LUNG LAVAGE; LYMPHOBLAST; LYMPHOCYTE SUBPOPULATION; MALE; NONHUMAN; PLASMA CELL; PNEUMONIA; PRIORITY JOURNAL; PROTECTION; PROVOCATION TEST; SWINE;

ACTINOBACILLUS PLEUROPNEUMONIAE; BACTERIA (MICROORGANISMS); MYCOPLASMA; SUS SCROFA;

EID: 0344631087     PISSN: 01681656     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-1656(99)00143-1     Document Type: Conference Paper

References (32)

1. Baarsch M.J., Scamurra R.W., Burger K., Foss D.L., Maheswaran S.K., Murtaugh M. Inflammatory cytokine expression in swine experimentally infected with Actinobacillus pleuropneumoniae. Infect. Immun. 63:1995;3587-5394.
2. Bienenstock J. The lung as an immunologic organ. Annu. Rev. Med. 35:1984;49-62.
3. Bossè J.T., Johnson R.P., Nemec M., Rosendal S. Protective local and systemic antibody responses of swine exposed to an aerosol of Actinobacillus pleuropneumoniae serotype 1. Infect. Immun. 60:1992;479-484.
4. Butler J.E., Feldbush T.L., McGivern P.L., Stewart N. The Enzyme-linked Immunosorbent assay (ELISA): a measure of antibody concentration or affinity? Immunochemistry. 15:1978;131-136.
5. Carr RM.M., Howard C.J., Sopp P., Manser J.M., Parsons K.R. Expression on porcine γδ lymphocytes of a phylogenetically conserved surface antigen previously restricted in expression to ruminant γδ T lymphocytes. Immunology. 81:1994;36-40.
6. Delventhal S., Hensel A., Petzoldt K., Pabst R. Cellular changes in the bronchoalveolar lavage (BAL) of pigs, following immunization by enteral or respiratory route. Clin. Exp. Immunol. 90:1992;223-227.
7. Delventhal S., Hensel A., Petzoldt K., Pabst R. Effects of microbial stimulation on the number, size and activity of bronchus-associated lymphoid tissue (BALT) structures in the pig. Int. J. Exp. Pathol. 73:1992;351-357.
8. Gehrke I., Pabst R. Cell composition and lymphocyte subsets in the bronchoalveolar lavage of normal pigs of different ages in comparison with germfree and pneumonic pigs. Lung. 168:1990;79-92.
9. Hensel A. Influence of serum and glucose additives on survival of Actinobacillus pleuropneumoniae aerosolized from the freeze-dried state. Appl. Environ. Microbiol. 60:1994;2155-2157.
10. Hensel A., Windt H., Stockhofe-Zurwieden N., Lödding H., Koch W., Petzoldt K. A porcine aerosol infection model for studying dose dependent effects caused by Actinobacillus pleuropneumoniae bacteria. J. Aerosol Med. 6:1993;73-88.
11. Hensel A., Stockhofe-Zurwieden N., Petzoldt K., Lubitz W. Oral immunization with viable or inactivated Actinobacillus pleuronpneumoniae serotype 9 induces pulmonary and systemic antibodies and protects against homologous aerosol challenge. Infect. Immun. 63:1995;3048-3053.
12. Hensel A., van Leengoed L.A.M.G., Szostak M.P., Windt H., Weissenböck H., Stockhofe-Zurwieden N., Katinger A., Stadler M., Ganter M., Bunka S., Pabst R., Lubitz W. Induction of protective immunity by aerosol or oral application of candidate vaccines in a dose-controlled pig aerosol infection model. J. Biotechnol. 44:1996;171-181.
13. Hutchinson C.A. III, Sinsheimer R.L. The process of infection with bacteriophage PhiX174. Mutations in a PhiX174 lysis gene. J. Mol. Biol. 18:1966;429-447.
14. Inzana T.J. Virulence properties of Actinobacillus pleuropneumoniae. Microbial Pathogen. 11:1991;305-316.
15. Loftager M.K., Eriksen L., Aasted B., Nielsen R. Protective immunity following immunisation of pigs with aerosol of Actinobacillus pleuropneumoniae serotype 2. Res. Vet. Sci. 55:1993;281-286.
16. McGhee J.R., Mestecky J., Dertzenbaugh M.T., Eldridge J.H., Hirasawa M., Kiyono H. The musosal immune system: from fundamental concepts to vaccine development. Vaccine. 10:1992;75-88.
17. McGill R., Tukey J.W., Larsen W.A. Variations of Box Plots. Am. Statist. 32:1978;12-16.
18. Nicolet J. Sur l'hemophilose du porc. III. Differenciation serologique de Haemophilus parahaemolyticus. Zbl. Bakteriol. I. Abt. Orig. 216:1971;487-495.
19. Paar F., Franz B., Nowotny N., Petzoldt K. Entwicklung eines Enzyme-linked Immunosorbent Assay (ELISA) zum Nachweis von Antikörpern in Pferdeseren gegen das Equine Herpesvirus 3. Wien. Tierärztl. Mschr. 76:1989;401-404.
20. Pabst R. Compartmentalization and kinetics of lymphoid cells in the lung. Reg. Immunol. 3:1990;62-71.
21. Pabst R., Binns R.M. Lymphocytes migrate from the bronchoalveolar space to regional bronchial lymph nodes. Am. J. Respir. Crit. Care Med. 151:1995;495-499.
22. Pabst T.R., Delventhal S., Gebert A., Hensel A., Petzoldt K. Lymphocyte subsets in bronchoalveolar lavage after exposure to Actinobacillus pleuropneumoniae in pigs previously immunized orally or by aerosol. Lung. 173:1995;233-241.
23. +dual expressing T-cells. Vet. Immunol. Immunopathol. 43:1994;53-62.
24. Remaut E., Stanssens P., Fiers W. Plasmid vectors for high-efficiency expression controlled by the PL promoter of coliphage lambda. Gene. 15:1981;81-93.
25. Szostak M.P., Wanner G., Lubitz W. Recombinant bacterial ghosts as vaccines. Res. Microbiol. 141:1990;1005-1007.
26. Szostak M.P., Auer T., Lubitz W. Immune response against recombinant bacterial ghosts carrying HIV-1 reverse transcriptase. Chanock R.M. et al. Vaccines 93: Modern Approaches to New Vaccines including Prevention of AIDS. 1993;419-425 Cold Spring Harbour Laboratory Press, Cold Spring Harbour, NY.
27. Szostak M.P., Hensel A., Eko F.O., Klein R., Auer T., Mader H., Haslberger A., Bunka S., Wanner G., Lubitz W. Bacterial ghosts: non-living candidate vaccines. J. Biotechnol. 44:1996;161-170.
28. Szostak M.P., Mader H., Truppe M., Kamal M., Eko F.O., Huter V., Marchart J., Jechlinger W., Haidinger W., Brand E., Denner E., Resch S., Dehlin E., Katinger A., Kuen B., Haslberger A., Hensel A., Lubitz W. Bacterial ghosts as multifunctional vaccine particles. Behring Inst. Mitt. 98:1997;191-196.
29. Tomb J.F., Barcak G.J., Chandler M.S., Redfield R.J., Smith H.O. Transposon mutogenesis, characterization, and cloning of transformation genes of Haemophilus influenzae Rd. J. Bacteriol. 171:1989;3796-3802.
30. Van Leengoed L.A.M.G., Kamp E.M. A method for bronchoalveolar lavage in live pigs. Vet. Quarterly. 11:1989;65-72.
31. Witte A., Lubitz W. Biochemical characterization of PHIX174 protein-E-mediated lysis of Eschericia coli. Eur. J. Biochem. 180:1989;393-398.
32. Yang H., Parkhouse R.M.E. Phenotypic classification of porcine lymphocyte subpopulations in blood and lymphoid tissues. Immunol. 89:1996;76-83.